drugset / Trial / NCT00869869

Melatonin Supplementation to Improve Sleep in Patients With Heart Failure

NCT00869869

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether melatonin can improve sleep, quality of life and markers of heart failure in patients with heart failure.

Timeline

Start
2009-03
Primary completion
2010-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2.5 mg Oral